A new pharmacological effect of levornidazole: Inhibition of NLRP3 inflammasome activation

2015/07/23 by Xingqi Wang, Shiyu Wang, Chunhui Hu +5 · 9 citations
Biochemistry, Genetics and Molecular Biology · Medicine · Immunology and Microbiology · #Inflammasome and immune disorders #Streptococcal Infections and Treatments #Immune Response and Inflammation

paper · doi:10.1016/j.bcp.2015.06.030

Cited by

• NOD-Like Receptor Protein 3 Inflammasome Priming and Activation in Barrett's Epithelial Cells. [europepmc]
• Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation. [europepmc]
• The Antioxidant Procyanidin Reduces Reactive Oxygen Species Signaling in Macrophages and Ameliorates Experimental Colitis in Mice. [europepmc]
• Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease. [europepmc]
• The Role of NLRP3 Inflammasome in Radiation-Induced Cardiovascular Injury. [europepmc]
• Roseotoxin B alleviates cholestatic liver fibrosis through inhibiting PDGF-B/PDGFR-β pathway in hepatic stellate cells. [europepmc]
• Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update. [europepmc]
• (-)-Epicatechin Ameliorates Monosodium Urate-Induced Acute Gouty Arthritis Through Inhibiting NLRP3 Inflammasome and the NF-κB Signaling Pathway. [europepmc]
• Targeting inflammasome-dependent mechanisms as an emerging pharmacological approach for osteoarthritis therapy. [europepmc]